7.70
-0.05(-0.65%)
Currency In USD
| Previous Close | 7.75 |
| Open | 7.78 |
| Day High | 7.81 |
| Day Low | 7.56 |
| 52-Week High | 11.25 |
| 52-Week Low | 5.81 |
| Volume | 145,696 |
| Average Volume | 306,488 |
| Market Cap | 515.34M |
| PE | 48.13 |
| EPS | 0.16 |
| Moving Average 50 Days | 7.42 |
| Moving Average 200 Days | 7.12 |
| Change | -0.05 |
If you invested $1000 in Bioventus Inc. (BVS) since IPO date, it would be worth $400.83 as of January 14, 2026 at a share price of $7.7. Whereas If you bought $1000 worth of Bioventus Inc. (BVS) shares 3 years ago, it would be worth $3,208.33 as of January 14, 2026 at a share price of $7.7.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 06, 2026 12:30 PM GMT
DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Con
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 25, 2025 9:15 PM GMT
DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive Officer, will present at the Piper Sandler
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
GlobeNewswire Inc.
Oct 28, 2025 11:00 AM GMT
DURHAM, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal ye